Effect of menstrual blood-derived stromal stem cells on proliferative capacity of peripheral blood mononuclear cells in allogeneic mixed lymphocyte reaction

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 5, 2012, Pages 804-809

  Nikoo, Shohreh ^a   Ebtekar, Massoumeh ^a   Jeddi Tehrani, Mahmood ^b   Shervin, Adel ^c   Bozorgmehr, Mahmood ^a   Kazemnejad, Somaieh ^c   Zarnani, Amir Hassan ^d,e  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b Monoclonal Antibody Research Center   (Iran)

^c Reproductive Biotechnology Research Center   (Iran)

^d AVICENNA RESEARCH INSTITUTE   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allogeneic mixed lymphocyte reaction; Menstrual blood; Proliferation; Regulatory T cells; Stromal stem cells

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD133 ANTIGEN; CD34 ANTIBODY; CD38 ANTIGEN; CD45 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ENDOGLIN; HERMES ANTIGEN; MONOCLONAL ANTIBODY; OCT 4A PROTEIN; PROTEIN; STRO 1 PROTEIN; UNCLASSIFIED DRUG;

ADHERENT CELL; ALLOGENEIC MIXED LYMPHOCYTE REACTION; ARTICLE; ASSAY; CELL CULTURE; CELL PROLIFERATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MENSTRUAL BLOOD STROMAL STEM CELL; MENSTRUATION; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; STEM CELL; STROMA CELL;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE CULTURE TEST, MIXED; MIDDLE AGED; STROMAL CELLS;

EID: 84861075623     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01800.x     Document Type: Article

References (16)

1. Edwards RG. Stem cells today: B1. Bone marrow stem cells. Reprod Biomed Online 2004; 9: 541-583. (Pubitemid 39517502)
2. Harris DT, Badowski M, Ahmad N, Gaballa MA. The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther 2007; 7: 1311-1322. (Pubitemid 47475652)
3. Parker AM, Katz AJ. Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther 2006; 6: 567-578. (Pubitemid 43837184)
4. De Coppi P, Bartsch GJ, Siddiqui MM et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-106. (Pubitemid 46087908)
5. Meng X, Ichim TE, Zhong J et al. Endometrial regenerative cells: A novel stem cell population. J Transl Med 2007; 5: 57-67.
6. Zhong Z, Patel AN, Ichim TE et al. Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med 2009; 7: 15-22.
7. Han X, Meng X, Yin Z et al. Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle 2009; 8: 606-610.
8. Hida N, Nishiyama N, Miyoshi S et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 2008; 26: 1695-1704.
9. Patel AN, Park E, Kuzman M, Benetti F, Silva FJ, Allickson JG. Multipotent menstrual blood stromal stem cells: Isolation, characterization, and differentiation. Cell Transplant 2008; 17: 303-311. (Pubitemid 351717333)
10. Deng W, Han Q, Liao L et al. Allogeneic bone marrowderived flk-1+Sca-1-mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol 2004; 32: 861-867. (Pubitemid 39166033)
11. Prevosto C, Zancolli M, Canevali P, Zocchi MR, Poggi A. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 2007; 92: 881-888. (Pubitemid 350144234)
12. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.Arthritis Rheum 2007; 56: 1175-1186. (Pubitemid 46608642)
13. Najar M, Rouas R, Raicevic G et al. Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: The importance of low cell ratio and role of interleukin-6. Cytotherapy 2009; 11: 570-583.
14. Fang L, Lange C, Engel M, Zander AR, Fehse B. Sensitive balance of suppressing and activating effects of mesenchymalstem cells on T-cell proliferation. Transplantation 2006; 82: 1370-1373. (Pubitemid 44832920)
15. Deuse T, Stubbendorff M, Tang-Quan K et al. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 2010; 20: 655-667.
16. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441. (Pubitemid 38586721)